Insmed (INSM) - P/S ratio

P/S ratio as of November 2026 (TTM): 16.6

According to Insmed's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 34.8. At the end of 2023 the company had a P/S ratio of 14.5.

P/S ratio history for Insmed from 2001 to 2023

PS ratio at the end of each year

Year	P/S ratio	Change
2023	14.5	31.67%
2022	11.0	-35.52%
2021	17.1	-17.05%
2020	20.6	31.43%
2019	15.7	-84.78%
2018	103
2017	N/A
2016	N/A
2015	N/A
2014	N/A	-100%
2013	57.9
2012	N/A	-100%
2011	17.1	20.19%
2010	14.3	47.61%
2009	9.67	101.06%
2008	4.81	-64.28%
2007	13.5	-85.03%
2006	89.9	-91.02%
2005	> 1000	38.83%
2004	721	-5.21%
2003	760	9874.26%
2002	7.62	-98.21%
2001	425

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Novartis NVS	5.39	-67.57%	🇨🇭 Switzerland
Gilead Sciences GILD	6.90	-58.51%	🇺🇸 USA
Vertex Pharmaceuticals VRTX	11.1	-33.19%	🇺🇸 USA
Sarepta Therapeutics SRPT	0.9581	-94.24%	🇺🇸 USA
Aerie Pharmaceuticals AERI	3.52	-78.81%	🇺🇸 USA
Array Technologies ARRY	0.6906	-95.84%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Insmed (INSM)

P/S ratio as of November 2026 (TTM): 16.6